[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

NO20081235L - Benzotiadiazolyfenylalkylaminderivater for anvendelse for behandling av lidelser lindret av monoamin reopptak - Google Patents

Benzotiadiazolyfenylalkylaminderivater for anvendelse for behandling av lidelser lindret av monoamin reopptak

Info

Publication number
NO20081235L
NO20081235L NO20081235A NO20081235A NO20081235L NO 20081235 L NO20081235 L NO 20081235L NO 20081235 A NO20081235 A NO 20081235A NO 20081235 A NO20081235 A NO 20081235A NO 20081235 L NO20081235 L NO 20081235L
Authority
NO
Norway
Prior art keywords
disorders
derivatives
treatment
monoamine reuptake
benzothiadiazolyphenylalkylamine
Prior art date
Application number
NO20081235A
Other languages
English (en)
Inventor
Puwen Zhang
Eugene John Trybulski
An Thien Vu
Eugene Anthony Terefenko
Casey Cameron Mccomas
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37684875&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20081235(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20081235L publication Critical patent/NO20081235L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Pregnancy & Childbirth (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

Foreliggende oppfinnelse angår benzotiadiazolylfenylalkylamin-derivater med formel I eller et farmasøytisk akseptabelt salt derav, preparater inneholdende disse derivater og metoder anvendelige for forebygging og behandling av lidelser som forbedres av monoamin-gjenopptak omfattende bl.a. vasomotor-symptomer (VMS), seksuell dysfunksjon, gastrointestinale og genitourinære lidelser, kronisk tretthets-syndrom, fibromyalgi-syndrom, nervesystem-lidelser og kombinasjoner derav, spesielt lidelser valgt fra gruppen bestående av alvorlig depressiv lidelse, vasomotor-symptomer, stress og trang urininkontinens, fibromyalgi, smerte, diabetisk nevropati og kombinasjoner derav.
NO20081235A 2005-09-29 2008-03-10 Benzotiadiazolyfenylalkylaminderivater for anvendelse for behandling av lidelser lindret av monoamin reopptak NO20081235L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72169305P 2005-09-29 2005-09-29
PCT/US2006/037962 WO2007041258A1 (en) 2005-09-29 2006-09-27 Benzothiadiazolyphenylalkylamine derivatives for use in the treatment of conditions ameliorated by monoamine reuptake

Publications (1)

Publication Number Publication Date
NO20081235L true NO20081235L (no) 2008-06-20

Family

ID=37684875

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20081235A NO20081235L (no) 2005-09-29 2008-03-10 Benzotiadiazolyfenylalkylaminderivater for anvendelse for behandling av lidelser lindret av monoamin reopptak

Country Status (19)

Country Link
US (1) US7601744B2 (no)
EP (1) EP1934193A1 (no)
JP (1) JP2009510095A (no)
KR (1) KR20080050453A (no)
CN (1) CN101277941A (no)
AR (1) AR055660A1 (no)
AU (1) AU2006297208A1 (no)
BR (1) BRPI0616462A2 (no)
CA (1) CA2624096A1 (no)
CR (1) CR9829A (no)
EC (1) ECSP088300A (no)
GT (1) GT200600441A (no)
IL (1) IL190273A0 (no)
NO (1) NO20081235L (no)
PE (1) PE20070544A1 (no)
RU (1) RU2008110082A (no)
TW (1) TW200804325A (no)
WO (1) WO2007041258A1 (no)
ZA (1) ZA200802774B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CL2007003590A1 (es) * 2006-12-12 2008-02-29 Wyeth Corp Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transt
US20090156826A1 (en) * 2007-12-12 2009-06-18 Wyeth Methods for the preparation of hydroxy-substituted aryl sulfamide compounds
CA2715192A1 (en) * 2008-02-19 2009-08-27 Adolor Corporation Beloxepin, its enantiomers, and analogs thereof for the treatment of pain
US20090233959A1 (en) 2008-02-19 2009-09-17 Adolor Corporation Beloxepin and analogs for the treatment of pain

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1291889A (zh) 1998-03-02 2001-04-18 伊莱利利公司 氟西汀盐酸盐用于降低热潮红
US7410996B2 (en) * 2002-11-05 2008-08-12 Eli Lilly And Company 3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake
US7491723B2 (en) * 2003-10-14 2009-02-17 Wyeth Alkanol and cycloalkanol-amine derivatives and methods of their use

Also Published As

Publication number Publication date
PE20070544A1 (es) 2007-07-26
TW200804325A (en) 2008-01-16
ZA200802774B (en) 2009-01-28
EP1934193A1 (en) 2008-06-25
ECSP088300A (es) 2008-04-28
IL190273A0 (en) 2009-09-22
CN101277941A (zh) 2008-10-01
CA2624096A1 (en) 2007-04-12
US7601744B2 (en) 2009-10-13
CR9829A (es) 2008-04-28
GT200600441A (es) 2007-09-19
US20070072918A1 (en) 2007-03-29
WO2007041258A1 (en) 2007-04-12
KR20080050453A (ko) 2008-06-05
JP2009510095A (ja) 2009-03-12
RU2008110082A (ru) 2009-11-10
AR055660A1 (es) 2007-08-29
BRPI0616462A2 (pt) 2011-06-21
AU2006297208A1 (en) 2007-04-12

Similar Documents

Publication Publication Date Title
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
TW200732296A (en) Novel compounds
NO20076059L (no) 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer
NO20085385L (no) Tiazolforbindelser som cannabinoidreseptorligander og anvendelser derav
TW200745003A (en) Novel compounds
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
NO20084318L (no) Inhibitorer av II-beta-hydroksystereoid dehydrogenase I
NO20065984L (no) Forbindelser og sammensetninger som PPAR modulatorer
NO20064892L (no) Heterosykliske fenylpropan-2-olderivater og relaterte forbindelser som modulatorer av norepinefrin (NE) og serotonin (5-HT) aktivitet og monoamin-gjenopptak for behandling av
EA200970337A1 (ru) Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения
WO2010126626A3 (en) Dual mechanism inhibitors for the treatment of disease
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
NO20092092L (no) Arylsulfamidderivater og fremgangsmater for anvendelse derav
WO2007140439A3 (en) Compounds as cannabinoid receptor ligands and uses thereof
NO20083057L (no) Sulfonyl substituerte 1H-indoler som ligander til 5-hydroksytryptamin reseptorer
EA201170795A1 (ru) Антагонисты ccr2 группы 4-азетидинил-1-гетероарил-циклогексанола
TW200640529A (en) Composition for treating mental health disorders
NO20065983L (no) Forbindelser og sammensetninger som PPAR modulatorer
EA201070423A1 (ru) Диарильные соединения оксадиазолов
WO2008136865A3 (en) (s)-n-stereoisomers of 7,8-saturated-4,5-epoxy-morphinanium analogs
WO2007050793A3 (en) Methods and compositions for the treatment of marfan syndrome and associated disorders
WO2008059370A8 (en) Substituted bicyclocarboxyamide compounds
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
TW200630336A (en) Novel compounds
TW200621690A (en) Novel compounds